Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZORRO: Zoledronic Acid and Healing After Arthroscopic Rotator Cuff Repair
2024-519082-22-00Phase 2Authorised
- Sponsor
- AUVA Trauma Center Vienna
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in rotator cuff tear and osteoporosis comparing Zoledronic acid arm with Placebo arm (2 arms). Primary endpoints: Tendon integrity at 6 months postoperative, Tendon integrity at 12 months postoperative and 2 more. Planned start Jan 2025; status: authorised.
02
Drugs
zoledronic acid
03
Conditions
rotator cuff tearosteoporosis
Beyond the preview
Go deeper on 2024-519082-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519082-22-00.